SlideShare a Scribd company logo
1 of 48
Biology, Clinical Manifestations,
and Treatment of Cancer
Chapter 9
Unit III: Cell Proliferation: Cancer
Cancer Epidemiology
Chapter 10
Cancer
• Derived from Greek word for crab,
karkinoma
• Malignant tumor
• Tumor
– Also referred to as a neoplasm—
new growth
Benign vs. Malignant Tumors
Benign Malignant
Grow slowly Grow rapidly
Well-defined capsule Not encapsulated
Not invasive Invasive
Well differentiated Poorly differentiated
Low mitotic index High mitotic index
Do not metastasize Can spread distantly
(metastasis)
Mitotic index = rate of growth
Classification and Nomenclature
• Benign tumors
– Named according to the tissues from which they
arise, and include the suffix “-oma”
• Lipoma
• Hemangioma
• Leiomyoma
• Chondroma
Classification and Nomenclature
• Malignant tumors
– Named according to the tissues from which they arise
• Malignant epithelial tumors are referred to as
carcinomas
– Adenocarcinoma (from glandular epithelium)
• Malignant CT tumors are referred to as sarcomas
– Rhabdomyosarcomas (from skeletal muscle)
Classification and Nomenclature
• Cancers of lymphatic tissue are lymphomas
• Cancers of blood-forming cells are leukemias
• Carcinoma in situ (CIS)
– Epithelial malignant tumors that have not broken
through BM or invaded the surrounding stroma
Classification and Nomenclature
Stages of Cancer Spread
• Stage 1: Confined to organ of origin
• Stage 2: Locally invasive
• Stage 3: Spread to lymph nodes
• Stage 4: Spread to distant sites
• CIS special case
Tumor Staging by TNM System
TUMOR
NODES
METASTASIS
Tumor Markers
• Tumor cell markers (biologic markers) are
substances produced by cancer cells or that
are found on plasma cell membranes, in the
blood, CSF, or urine
– Hormones (Epi – in blood, adrenal medullary
tumor)
– Enzymes
– Genes
– Antigens (PSA – in blood, prostate cancer)
– Antibodies
Hallmarks of Cancer
Viruses and Cancer
• Implicated
– Hepatitis B and C viruses
– Epstein-Barr virus (EBV)
– Kaposi’s sarcoma herpesvirus (KSHV)
– Human papillomavirus (HPV)
– Human T cell leukemia–lymphoma virus (HTLV)
Bacterial Cause of Cancer
• Helicobacter pylori
– Chronic infections are associated with:
• Peptic ulcer disease
• Stomach carcinoma
• Mucosa-associated lymphoid tissue
lymphomas
Inflammation and Cancer
• Chronic inflammation is an important
factor in development of cancer
– Cytokine release from inflammatory cells
– Free radicals
– Mutation promotion
– Decreased response to DNA damage
Tumor Spread
• Direct invasion of contiguous organs
– Known as local spread
• Metastases to distant organs
– Lymphatics and blood
• Metastases by way of implantation
Local Spread
• Invasion
– Cellular multiplication
• Mitotic rate vs. cellular death rate
– Mechanical pressure
– Release of lytic enzymes
– Decreased cell-to-cell adhesion
– Increased motility
• Intravasation
• Extravasation
Three-Step Theory of Invasion
• Tumor cell attachment
– Fibronectin and laminin
• Degradation or dissolution of the matrix
– Enzymes
• Locomotion into the matrix
– Invadopodia (pseudopodia)
HeLa cell
• a cell type in an immortal cell line used in research
• one of the oldest, most commonly used human cell lines
• derived from cervical cancer cells taken from Henrietta Lacks
• patient eventually died of her cancer on October 4, 1951
• cell line was found to be remarkably durable
• cells propagated by George Otto Gey
• first human cell line to prove successful in vitro, which was a
scientific achievement for the benefit of science
• neither Lacks nor her family gave Gey permission
– (at that time, permission was neither required nor sought)
• HeLa cells were used by Jonas Salk to test the first
polio vaccine in the 1950’s
Concept Check
• 1. Neoplasia a. abnormal proliferating cells w/ higher
degree of autonomy
• 2. Anaplasia b. lack of differentiation, primitive cells
• 3. Autonomy c. cancer cells’ independence from normal
cell controls
• 4. Tumor markers d. substances produced by cancer cells
• 5. Which characterizes cancer cells?
– A. Poorly differentiated
– B. Metastasis
– C. Infiltrative growth
– D. Poor cell cohesiveness
– E. All of the above
• 6. Which is/are not malignant?
– A. Glioma
– B. Adenocarcinoma
– C. Rhabdomyoma
– D. Leukemia
– E. A and C
• 7. Metastasis is:
– A. Alteration in normal cell growth
– B. Growth of benign or or malignant cells
– C. Mutational
– D. Ability to establish a secondary neoplasm at a new site
• 8. CIS is:
– A. Preinvasive
– B. Glandular or epithelial lesion
– C. Teratoma
– D. Carcinoma that has broken through BM
– E. Both a and b are correct
Cancer Epidemiology
Chapter 10
Environmental Risk Factors
Increased Decreased
• Tobacco * Exercise
• Radiation * Proper Diet
– Ionizing
– UV
• Alcohol
• Sexual Behavior
• Diet
• Obesity
• Occupational Hazards
• Electromagnetic Fields ?
Environmental Risk Factors
• Tobacco
– Multipotent carcinogenic mixture
– Linked to cancers of the lung, lower urinary tract,
aerodigestive tract, liver, kidney, pancreas, cervix
– Linked to myeloid leukemia
Environmental Risk Factors
• Ionizing radiation
– Emission from x-rays, radioisotopes, and other
radioactive sources
– Exposure causes cell death, gene mutations, and
chromosome aberrations
– Bystander effects
– Poor gene repair
– Changes in gap junction intercellular
communication
Environmental Risk Factors
• Ultraviolet radiation
– Causes basal cell carcinoma, squamous cell
carcinoma, and melanoma
– Principal source is sunlight
– Ultraviolet A (UVA) and ultraviolet B (UVB)
– Promotes skin inflammation and release of
free radicals
Environmental Risk Factors
• Alcohol consumption
– Risk factor for oral cavity, pharynx,
hypopharynx, larynx, esophagus, and
liver cancers
– Cigarette/alcohol combination increases
a person’s risk
Environmental Risk Factors
• Sexual reproductive behavior
–Carcinogenic types of human papilloma virus
–High-risk HPV
Environmental Risk Factors
• Physical activity
– Reduces cancer risk
• Decreases insulin and insulin-like growth factors
• Decreases obesity
• Decreases inflammatory mediators and free
radicals
• Increased gut motility
Environmental Risk Factors
• Occupational hazards
– Substantial number of occupational carcinogenic
agents
• Asbestos
• Dyes, rubber, paint, explosives, rubber cement,
heavy metals, air pollution, etc.
• Radon
Environmental Risk Factors
• Electromagnetic fields
– Carcinogenic?
• Are they, or aren’t they?
Environmental Risk Factors
• Diet
–Xenobiotics
• Toxic, mutagenic, and carcinogenic chemicals in
food
• Activated by phase I activation enzymes
• Defense mechanisms
– Phase II detoxification enzymes
• Examples
– Compounds produced in the cooking of fat, meat, or
proteins
– Alkaloids or mold by-products
Environmental Risk Factors
• Obesity
– Correlates with the body mass index (BMI)
– Adipose tissue is active endocrine and
metabolic tissue
Environmental Risk Factors
• Obesity
– In response to endocrine and metabolic signaling,
adipose tissue releases free fatty acids
• Increased free fatty acids gives rise to insulin
resistance and causes chronic hyperinsulinemia
• Correlates with colon, breast, pancreatic, and
endometrial cancers
Clinical Manifestations of Cancer
• Pain
– Little or no pain is associated with early
stages of malignancy
– Influenced by fear, anxiety, sleep loss,
fatigue, and overall physical deterioration
– Mechanisms
• Pressure, obstruction, invasion of sensitive
structures, stretching of visceral surfaces, tissue
destruction, and inflammation
Clinical Manifestations of Cancer
• Fatigue
– Subjective clinical manifestation
– Tiredness, weakness, lack of energy, exhaustion,
lethargy, inability to concentrate, depression,
sleepiness, boredom, and lack of motivation
– Suggested causes
• Sleep disturbance, biochemical changes (cytokines),
secondary to disease and treatment, psychosocial
factors, level of activity, nutritional status, and
environmental factors
Clinical Manifestations of Cancer
• Syndrome of cachexia (Gr. “bad condition”)
– Most severe form of malnutrition
– Present in 80% of cancer patients at death
– Includes:
• Anorexia, early satiety, weight loss, anemia,
asthenia, taste alterations, and altered protein,
lipid, and CHO metabolism
Cachexia
Clinical Manifestations of Cancer
• Anemia
– A decrease of hemoglobin in the blood
– Mechanisms
• Chronic bleeding resulting in iron
deficiency, severe malnutrition, medical
therapies, or malignancy in blood-
forming organs
Clinical Manifestations of Cancer
• Leukopenia and thrombocytopenia
– Direct tumor invasion to the bone marrow
causes leukopenia and thrombocytopenia
– Chemotherapy drugs are toxic to the bone
marrow
• Infection
– Risk increases when the absolute neutrophil
and lymphocyte counts fall
Cancer Treatment
• Chemotherapy
– Use of nonselective cytotoxic drugs that
target vital cellular machinery or metabolic
pathways critical to both malignant and
normal cell growth and replication
– Goal
• Eliminate enough tumor cells so body’s
defense can eradicate any remaining cells
Cancer Treatment
• Chemotherapy
– Compartments
1: cells undergoing mitosis and cytokinesis
2: cells capable of entering the cell cycle in G1 phase
3: cells not dividing or have irreversibly left cell cycle
–Cells in compartment 3 will die a natural death
Chemotherapy
Cancer Treatment
• Ionizing radiation
– Eradicate cancer without excessive toxicity
• Avoid damage to normal structures
– Ionizing radiation damages the cancer cell’s DNA
• Surgery
– Biopsy and lymph node sampling
• Sentinel nodes
– Debulking surgery –remove most of tumor
– Palliative surgery – relief of symptoms
• Hormone therapy
– Receptor activation or blockage
– Interferes with cellular growth and signaling
Cancer Treatment
• Immunotherapy
– Theoretically, antitumor responses can selectively
eliminate cancer cells while sparing normal cells
– Immune memory is long lived
– Numerous immunologic mechanisms are capable of
rejecting different types of cancer
– Biologic response modifiers (BRMs)
Cancer Treatment
• Other forms of immunotherapy
– Interferon administration
– Antigens
– Effector cell lymphokines
– Monoclonal antibodies
Side Effects of Cancer Treatment
• Gastrointestinal tract
• Bone marrow
• Hair and skin
• Reproductive tract
Concept Check
• 1. Likely cause for fatigue in cancer patients:
– A. Biochemical changes due to treatment
– B. Muscle loss
– C. Pychologic factors
– D. All of the above
• 2. The pain experience with cancer:
– A. Affects the patient only in the early stages
– B. Occurs in bone metastasis
– C. Due to tissue necrosis
– D. Both b and c are correct

More Related Content

Similar to Bio217F12Unit3Ch910HandoutCancerEpidem.ppt

Similar to Bio217F12Unit3Ch910HandoutCancerEpidem.ppt (20)

Cancer ppt
Cancer pptCancer ppt
Cancer ppt
 
ONCOLOGY.pptx
ONCOLOGY.pptxONCOLOGY.pptx
ONCOLOGY.pptx
 
Normal vs cancer -Pooja Murkar
Normal vs cancer -Pooja MurkarNormal vs cancer -Pooja Murkar
Normal vs cancer -Pooja Murkar
 
ANTICANCER.ppt
ANTICANCER.pptANTICANCER.ppt
ANTICANCER.ppt
 
Cancer - Complete Concept.pptx
Cancer - Complete Concept.pptxCancer - Complete Concept.pptx
Cancer - Complete Concept.pptx
 
Cancer
CancerCancer
Cancer
 
Cellular and Molecular Tumor Markers by Prof. Mohamed Labib Salem, PhD (Lux...
Cellular and Molecular Tumor  Markers  by Prof. Mohamed Labib Salem, PhD (Lux...Cellular and Molecular Tumor  Markers  by Prof. Mohamed Labib Salem, PhD (Lux...
Cellular and Molecular Tumor Markers by Prof. Mohamed Labib Salem, PhD (Lux...
 
Carcinogens
Carcinogens  Carcinogens
Carcinogens
 
oncology.ppt
oncology.pptoncology.ppt
oncology.ppt
 
Onco Emergency 2020.pptx
Onco Emergency 2020.pptxOnco Emergency 2020.pptx
Onco Emergency 2020.pptx
 
Oncology 2.pptx
Oncology 2.pptxOncology 2.pptx
Oncology 2.pptx
 
Cancer by Dr.Hesham Al-Nouby
Cancer by Dr.Hesham Al-NoubyCancer by Dr.Hesham Al-Nouby
Cancer by Dr.Hesham Al-Nouby
 
Cancer
CancerCancer
Cancer
 
CANCER.pptx
CANCER.pptxCANCER.pptx
CANCER.pptx
 
neoplasia.pptx
neoplasia.pptxneoplasia.pptx
neoplasia.pptx
 
Cellular-abberation.pptx
Cellular-abberation.pptxCellular-abberation.pptx
Cellular-abberation.pptx
 
Cancer by dr.reeena
Cancer by dr.reeenaCancer by dr.reeena
Cancer by dr.reeena
 
cancer how when and what
cancer how when and whatcancer how when and what
cancer how when and what
 
Cancer Biology bbbbbnnnnbbbbjnbbbbbbbbbh
Cancer Biology bbbbbnnnnbbbbjnbbbbbbbbbhCancer Biology bbbbbnnnnbbbbjnbbbbbbbbbh
Cancer Biology bbbbbnnnnbbbbjnbbbbbbbbbh
 
Nursing management of patients with oncological conditions
Nursing management of patients with oncological conditionsNursing management of patients with oncological conditions
Nursing management of patients with oncological conditions
 

Recently uploaded

Recently uploaded (20)

Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 

Bio217F12Unit3Ch910HandoutCancerEpidem.ppt

  • 1. Biology, Clinical Manifestations, and Treatment of Cancer Chapter 9 Unit III: Cell Proliferation: Cancer Cancer Epidemiology Chapter 10
  • 2. Cancer • Derived from Greek word for crab, karkinoma • Malignant tumor • Tumor – Also referred to as a neoplasm— new growth
  • 3. Benign vs. Malignant Tumors Benign Malignant Grow slowly Grow rapidly Well-defined capsule Not encapsulated Not invasive Invasive Well differentiated Poorly differentiated Low mitotic index High mitotic index Do not metastasize Can spread distantly (metastasis) Mitotic index = rate of growth
  • 4. Classification and Nomenclature • Benign tumors – Named according to the tissues from which they arise, and include the suffix “-oma” • Lipoma • Hemangioma • Leiomyoma • Chondroma
  • 5. Classification and Nomenclature • Malignant tumors – Named according to the tissues from which they arise • Malignant epithelial tumors are referred to as carcinomas – Adenocarcinoma (from glandular epithelium) • Malignant CT tumors are referred to as sarcomas – Rhabdomyosarcomas (from skeletal muscle)
  • 6. Classification and Nomenclature • Cancers of lymphatic tissue are lymphomas • Cancers of blood-forming cells are leukemias • Carcinoma in situ (CIS) – Epithelial malignant tumors that have not broken through BM or invaded the surrounding stroma
  • 8. Stages of Cancer Spread • Stage 1: Confined to organ of origin • Stage 2: Locally invasive • Stage 3: Spread to lymph nodes • Stage 4: Spread to distant sites • CIS special case
  • 9. Tumor Staging by TNM System TUMOR NODES METASTASIS
  • 10. Tumor Markers • Tumor cell markers (biologic markers) are substances produced by cancer cells or that are found on plasma cell membranes, in the blood, CSF, or urine – Hormones (Epi – in blood, adrenal medullary tumor) – Enzymes – Genes – Antigens (PSA – in blood, prostate cancer) – Antibodies
  • 12. Viruses and Cancer • Implicated – Hepatitis B and C viruses – Epstein-Barr virus (EBV) – Kaposi’s sarcoma herpesvirus (KSHV) – Human papillomavirus (HPV) – Human T cell leukemia–lymphoma virus (HTLV)
  • 13. Bacterial Cause of Cancer • Helicobacter pylori – Chronic infections are associated with: • Peptic ulcer disease • Stomach carcinoma • Mucosa-associated lymphoid tissue lymphomas
  • 14. Inflammation and Cancer • Chronic inflammation is an important factor in development of cancer – Cytokine release from inflammatory cells – Free radicals – Mutation promotion – Decreased response to DNA damage
  • 15. Tumor Spread • Direct invasion of contiguous organs – Known as local spread • Metastases to distant organs – Lymphatics and blood • Metastases by way of implantation
  • 16. Local Spread • Invasion – Cellular multiplication • Mitotic rate vs. cellular death rate – Mechanical pressure – Release of lytic enzymes – Decreased cell-to-cell adhesion – Increased motility • Intravasation • Extravasation
  • 17. Three-Step Theory of Invasion • Tumor cell attachment – Fibronectin and laminin • Degradation or dissolution of the matrix – Enzymes • Locomotion into the matrix – Invadopodia (pseudopodia)
  • 18. HeLa cell • a cell type in an immortal cell line used in research • one of the oldest, most commonly used human cell lines • derived from cervical cancer cells taken from Henrietta Lacks • patient eventually died of her cancer on October 4, 1951 • cell line was found to be remarkably durable • cells propagated by George Otto Gey • first human cell line to prove successful in vitro, which was a scientific achievement for the benefit of science • neither Lacks nor her family gave Gey permission – (at that time, permission was neither required nor sought) • HeLa cells were used by Jonas Salk to test the first polio vaccine in the 1950’s
  • 19. Concept Check • 1. Neoplasia a. abnormal proliferating cells w/ higher degree of autonomy • 2. Anaplasia b. lack of differentiation, primitive cells • 3. Autonomy c. cancer cells’ independence from normal cell controls • 4. Tumor markers d. substances produced by cancer cells
  • 20. • 5. Which characterizes cancer cells? – A. Poorly differentiated – B. Metastasis – C. Infiltrative growth – D. Poor cell cohesiveness – E. All of the above • 6. Which is/are not malignant? – A. Glioma – B. Adenocarcinoma – C. Rhabdomyoma – D. Leukemia – E. A and C
  • 21. • 7. Metastasis is: – A. Alteration in normal cell growth – B. Growth of benign or or malignant cells – C. Mutational – D. Ability to establish a secondary neoplasm at a new site • 8. CIS is: – A. Preinvasive – B. Glandular or epithelial lesion – C. Teratoma – D. Carcinoma that has broken through BM – E. Both a and b are correct
  • 23. Environmental Risk Factors Increased Decreased • Tobacco * Exercise • Radiation * Proper Diet – Ionizing – UV • Alcohol • Sexual Behavior • Diet • Obesity • Occupational Hazards • Electromagnetic Fields ?
  • 24. Environmental Risk Factors • Tobacco – Multipotent carcinogenic mixture – Linked to cancers of the lung, lower urinary tract, aerodigestive tract, liver, kidney, pancreas, cervix – Linked to myeloid leukemia
  • 25. Environmental Risk Factors • Ionizing radiation – Emission from x-rays, radioisotopes, and other radioactive sources – Exposure causes cell death, gene mutations, and chromosome aberrations – Bystander effects – Poor gene repair – Changes in gap junction intercellular communication
  • 26. Environmental Risk Factors • Ultraviolet radiation – Causes basal cell carcinoma, squamous cell carcinoma, and melanoma – Principal source is sunlight – Ultraviolet A (UVA) and ultraviolet B (UVB) – Promotes skin inflammation and release of free radicals
  • 27. Environmental Risk Factors • Alcohol consumption – Risk factor for oral cavity, pharynx, hypopharynx, larynx, esophagus, and liver cancers – Cigarette/alcohol combination increases a person’s risk
  • 28. Environmental Risk Factors • Sexual reproductive behavior –Carcinogenic types of human papilloma virus –High-risk HPV
  • 29. Environmental Risk Factors • Physical activity – Reduces cancer risk • Decreases insulin and insulin-like growth factors • Decreases obesity • Decreases inflammatory mediators and free radicals • Increased gut motility
  • 30. Environmental Risk Factors • Occupational hazards – Substantial number of occupational carcinogenic agents • Asbestos • Dyes, rubber, paint, explosives, rubber cement, heavy metals, air pollution, etc. • Radon
  • 31. Environmental Risk Factors • Electromagnetic fields – Carcinogenic? • Are they, or aren’t they?
  • 32. Environmental Risk Factors • Diet –Xenobiotics • Toxic, mutagenic, and carcinogenic chemicals in food • Activated by phase I activation enzymes • Defense mechanisms – Phase II detoxification enzymes • Examples – Compounds produced in the cooking of fat, meat, or proteins – Alkaloids or mold by-products
  • 33. Environmental Risk Factors • Obesity – Correlates with the body mass index (BMI) – Adipose tissue is active endocrine and metabolic tissue
  • 34. Environmental Risk Factors • Obesity – In response to endocrine and metabolic signaling, adipose tissue releases free fatty acids • Increased free fatty acids gives rise to insulin resistance and causes chronic hyperinsulinemia • Correlates with colon, breast, pancreatic, and endometrial cancers
  • 35. Clinical Manifestations of Cancer • Pain – Little or no pain is associated with early stages of malignancy – Influenced by fear, anxiety, sleep loss, fatigue, and overall physical deterioration – Mechanisms • Pressure, obstruction, invasion of sensitive structures, stretching of visceral surfaces, tissue destruction, and inflammation
  • 36. Clinical Manifestations of Cancer • Fatigue – Subjective clinical manifestation – Tiredness, weakness, lack of energy, exhaustion, lethargy, inability to concentrate, depression, sleepiness, boredom, and lack of motivation – Suggested causes • Sleep disturbance, biochemical changes (cytokines), secondary to disease and treatment, psychosocial factors, level of activity, nutritional status, and environmental factors
  • 37. Clinical Manifestations of Cancer • Syndrome of cachexia (Gr. “bad condition”) – Most severe form of malnutrition – Present in 80% of cancer patients at death – Includes: • Anorexia, early satiety, weight loss, anemia, asthenia, taste alterations, and altered protein, lipid, and CHO metabolism
  • 39. Clinical Manifestations of Cancer • Anemia – A decrease of hemoglobin in the blood – Mechanisms • Chronic bleeding resulting in iron deficiency, severe malnutrition, medical therapies, or malignancy in blood- forming organs
  • 40. Clinical Manifestations of Cancer • Leukopenia and thrombocytopenia – Direct tumor invasion to the bone marrow causes leukopenia and thrombocytopenia – Chemotherapy drugs are toxic to the bone marrow • Infection – Risk increases when the absolute neutrophil and lymphocyte counts fall
  • 41. Cancer Treatment • Chemotherapy – Use of nonselective cytotoxic drugs that target vital cellular machinery or metabolic pathways critical to both malignant and normal cell growth and replication – Goal • Eliminate enough tumor cells so body’s defense can eradicate any remaining cells
  • 42. Cancer Treatment • Chemotherapy – Compartments 1: cells undergoing mitosis and cytokinesis 2: cells capable of entering the cell cycle in G1 phase 3: cells not dividing or have irreversibly left cell cycle –Cells in compartment 3 will die a natural death
  • 44. Cancer Treatment • Ionizing radiation – Eradicate cancer without excessive toxicity • Avoid damage to normal structures – Ionizing radiation damages the cancer cell’s DNA • Surgery – Biopsy and lymph node sampling • Sentinel nodes – Debulking surgery –remove most of tumor – Palliative surgery – relief of symptoms • Hormone therapy – Receptor activation or blockage – Interferes with cellular growth and signaling
  • 45. Cancer Treatment • Immunotherapy – Theoretically, antitumor responses can selectively eliminate cancer cells while sparing normal cells – Immune memory is long lived – Numerous immunologic mechanisms are capable of rejecting different types of cancer – Biologic response modifiers (BRMs)
  • 46. Cancer Treatment • Other forms of immunotherapy – Interferon administration – Antigens – Effector cell lymphokines – Monoclonal antibodies
  • 47. Side Effects of Cancer Treatment • Gastrointestinal tract • Bone marrow • Hair and skin • Reproductive tract
  • 48. Concept Check • 1. Likely cause for fatigue in cancer patients: – A. Biochemical changes due to treatment – B. Muscle loss – C. Pychologic factors – D. All of the above • 2. The pain experience with cancer: – A. Affects the patient only in the early stages – B. Occurs in bone metastasis – C. Due to tissue necrosis – D. Both b and c are correct

Editor's Notes

  1. Fats, glial cells, uterine SMC, cartilage
  2. Adrenal medulla tumor - pheochromocytoma
  3. Currently accepted that – multiple mutations are nec. for cancer to dev. A number of cell control paths must be altered: 1. cancer cells proliferate in absence of growth factors 2. antigrowth signals (contact inhibition) – inactivated in cancer 3. & 4. apoptosis = self destruction path (like excessive growth) is disabled  excess growth takes place 5. Angiogenesis – new blood vessel growth 6. VEGF (vascular endothel. GF) is inactivated will fight cancer growth and spread
  4. The cells were later commercialized, although never patented in their original form. Then, as now, there was no requirement to inform a patient, or their relatives, about such matters because discarded material, or material obtained during surgery, diagnosis or therapy, was the property of the physician and/or medical institution. This issue and Mrs. Lacks' situation was brought up in the Supreme Court of California case of Moore v. Regents of the University of California. The court ruled that a person's discarded tissue and cells are not their property and can be commercialized.(As stated in The Immortal Life of Henrietta Lacks by Rebecca Skloot) Initially, the cell line was said to be named after a "Helen Lane" or "Helen Larson", in order to preserve Lacks' anonymity. Despite this attempt, her real name was used by the press within a few years of her death. These cells are treated as cancer cells, as they are descended from a biopsy taken from a visible lesion on the cervix as part of Mrs. Lacks' diagnosis of cancer. A debate still continues on the classification of the cells.[citation needed] HeLa cells are termed "immortal" in that they can divide an unlimited number of times in a laboratory cell culture plate as long as fundamental cell survival conditions are met (i.e. being maintained and sustained in a suitable environment). There are many strains of HeLa cells as they continue to evolve by being grown in cell cultures, but all HeLa cells are descended from the same tumor cells removed from Mrs. Lacks. It has been estimated that the total number of HeLa cells that have been propagated in cell culture far exceeds the total number of cells that were in Henrietta Lacks' body.[5] Since that time HeLa cells have been used for "research into cancer, AIDS, the effects of radiation and toxic substances, gene mapping, and countless other scientific pursuits".[6] According to author Rebecca Skloot, by 2009, "more than 60,000 scientific articles had been published about research done on HeLa, and that number was increasing steadily at a rate of more than 300 papers each month."[7] Rebecca Skloot – author of The Immortal Life of Henrietta Lacks 2009 http://www.jhu.edu/jhumag/0400web/01.html
  5. 1. A 2.B 3.C 4.D
  6. 5. E 6. E (a and c)
  7. 7. D new growth at new site 8. e
  8. EMR or EMF http://quwave.com/EMF-Pollution.html?gclid=CIyygLqm76kCFRYf3wodghjoYw
  9. Xeno = foreigner, stranger; bios = life
  10. 1. D 2. D